DOT1L and leukemia: Treatment of MLL-rearranged leukemia with EPZ00477 or EPZ-5676 (potent and selective amino nucleoside inhibitors of DOT1L histone methyltransferase activity) causes cell death in acute leukemia lines bearing MLL translocations [86,87].